News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Caligan Partners LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/17/2023 |
4
| Caligan Partners LP (10% Owner) has filed a Form 4 on ALIMERA SCIENCES INC|
Txns:
| Converted 2,924,761 shares
@ $2.1, valued at
$6.1M
Converted 13,431,616 shares
@ $1.7, valued at
$22.8M
Converted 2,924,761 options to buy
@ $2.1, valued at
$6.1M
Converted 13,431,616 options to buy
@ $1.7, valued at
$22.8M
|
|
| 08/17/2023 |
SC 13D
| Caligan Partners LP reports a 6.2% stake in Anika Therapeutics, Inc. |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/11/2023 |
3
| Caligan Partners LP (10% Owner) has filed a Form 3 on ALIMERA SCIENCES INC |
| 08/03/2023 |
SC 13D/A
| Caligan Partners LP reports a 33.1% stake in Alimera Sciences, Inc. |
| 07/03/2023 |
4
| Caligan Partners LP (10% Owner) has filed a Form 4 on STANDARD BIOTOOLS INC.|
Txns:
| Disposed of 108,879 shares
@ $0
Disposed of 670,466 shares
@ $0 |
|
| 07/03/2023 |
SC 13D/A
| Caligan Partners LP reports a 9.9% stake in Standard BioTools, Inc. |
| 06/02/2023 |
4
| JOHNSON DAVID EDWARD (Director) has filed a Form 4 on EXELIXIS, INC.|
Txns:
| Granted 18,176 shares
@ $0
Granted 36,353 options to buy
@ $19.28, valued at
$700.9k
|
|
| 06/02/2023 |
3
| JOHNSON DAVID EDWARD (Director) has filed a Form 3 on EXELIXIS, INC. |
| 06/02/2023 |
SC 13D/A
| Caligan Partners LP reports a 0.3% stake in Exelixis, Inc. |
| 05/18/2023 |
SC 13D/A
| Caligan Partners LP reports a 10% stake in Alimera Sciences, Inc. |
| 05/15/2023 |
13F-HR/A
| Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend] |
| 05/15/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 03/28/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/27/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/20/2023 |
SC 13D
| Caligan Partners LP reports a 0.3% stake in Exelixis, Inc. |
| 12/30/2022 |
4
| Caligan Partners LP (10% Owner) has filed a Form 4 on STANDARD BIOTOOLS INC.|
Txns:
| Disposed of 2,868,037 shares
@ $0 |
|
| 12/30/2022 |
SC 13D/A
| Caligan Partners LP reports a 10.8% stake in Standard BioTools, Inc. |
| 12/09/2022 |
SC 13D/A
| Caligan Partners LP reports a 4.6% stake in ADMA Biologics, Inc. |
| 09/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2022 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2022 |
SC 13D/A
| Caligan Partners LP reports a 12.3% stake in Standard BioTools, Inc. |
| 05/02/2022 |
4
| Caligan Partners LP (10% Owner) has filed a Form 4 on STANDARD BIOTOOLS INC.|
Txns:
| Bought 27,600 shares
@ $2.4, valued at
$66.2k
Bought 247,400 shares
@ $2.66, valued at
$658.1k
Bought 125,000 shares
@ $2.81, valued at
$351.3k
|
|
| 04/18/2022 |
4
| Caligan Partners LP (10% Owner) has filed a Form 4 on Liquidia Corp|
Txns:
| Bought 1,764,705 shares
@ $5.1, valued at
$9M
|
|
| 04/13/2022 |
4
| Caligan Partners LP (10% Owner) has filed a Form 4 on STANDARD BIOTOOLS INC.|
Txns:
| Bought 145,000 shares
@ $3.87, valued at
$561.2k
Bought 50,000 shares
@ $3.6, valued at
$180k
|
|
|
|
|